Literature DB >> 23121975

A distinct tolerogenic subset of splenic IDO(+)CD11b(+) dendritic cells from orally tolerized mice is responsible for induction of systemic immune tolerance and suppression of collagen-induced arthritis.

Min-Jung Park1, Kyung-Su Park, Hyun-Sil Park, Mi-La Cho, Sue-Yun Hwang, So-Youn Min, Mi-Kyung Park, Sung-Hwan Park, Ho-Youn Kim.   

Abstract

In oral tolerance, locally instigated tolerance in the gut propagate to systemic tolerance. In order to investigate the mechanism, we analyzed indoleamine 2,3-dioxygenase (IDO) expression in splenic dendritic cell (DC) subsets and tested whether DCs suppress collagen-induced arthritis (CIA) by inducing regulatory T cells (Tregs). The proportion of IDO-expressing cells was higher in the CD11b(+) subset of splenic DCs from orally tolerized CIA mice. These DCs suppressed type II collagen-specific T cell proliferation and promoted Treg induction from CD4(+)CD25(-) T cells using transforming growth factor-β. These DCs also increased the expression of cytotoxic T lymphocyte antigen-4 and programmed death-1 on Tregs. When adoptively transferred, spenic IDO-expressing CD11b(+) DCs from tolerized animals suppressed the development of arthritis, increased the Treg/Th17 cell ratio, and decreased the production of inflammatory cytokines in the spleen. Taken together, a distinct subset of splenic IDO(+)CD11b(+)DCs is responsible for the systemic immune regulation in oral tolerance.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23121975     DOI: 10.1016/j.cellimm.2012.06.009

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  16 in total

1.  Effect of bone marrow-derived CD11b(+)F4/80 (+) immature dendritic cells on the balance between pro-inflammatory and anti-inflammatory cytokines in DBA/1 mice with collagen-induced arthritis.

Authors:  Jingjing Fu; Lingling Zhang; Shanshan Song; Kangliang Sheng; Ying Li; Peipei Li; Shasha Song; Qingtong Wang; Jianhong Chu; Wei Wei
Journal:  Inflamm Res       Date:  2014-01-24       Impact factor: 4.575

Review 2.  Dendritic cells as gatekeepers of tolerance.

Authors:  Ari Waisman; Dominika Lukas; Björn E Clausen; Nir Yogev
Journal:  Semin Immunopathol       Date:  2016-07-25       Impact factor: 9.623

Review 3.  Trial watch: IDO inhibitors in cancer therapy.

Authors:  Erika Vacchelli; Fernando Aranda; Alexander Eggermont; Catherine Sautès-Fridman; Eric Tartour; Eugene P Kennedy; Michael Platten; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-12-15       Impact factor: 8.110

4.  IDO1 and TGF-β Mediate Protective Effects of IFN-α in Antigen-Induced Arthritis.

Authors:  Jaya Prakash Chalise; Maria Teresa Pallotta; Sudeep Chenna Narendra; Björn Carlsson; Alberta Iacono; Joanitah Namale; Louis Boon; Ursula Grohmann; Mattias Magnusson
Journal:  J Immunol       Date:  2016-09-19       Impact factor: 5.422

5.  Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer.

Authors:  Mariela A Moreno Ayala; María Florencia Gottardo; María Soledad Gori; Alejandro Javier Nicola Candia; Carla Caruso; Andrea De Laurentiis; Mercedes Imsen; Slobodanka Klein; Elisa Bal de Kier Joffé; Gabriela Salamone; Maria G Castro; Adriana Seilicovich; Marianela Candolfi
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-21       Impact factor: 4.553

6.  Indoleamine 2,3-dioxygenase activity contributes to local immune suppression in the skin expressing human papillomavirus oncoprotein e7.

Authors:  Deepak Mittal; Andrew J Kassianos; Lee S Tran; Anne-Sophie Bergot; Christine Gosmann; Janin Hofmann; Antje Blumenthal; Graham R Leggatt; Ian H Frazer
Journal:  J Invest Dermatol       Date:  2013-05-07       Impact factor: 8.551

7.  Tolerogenic splenic IDO (+) dendritic cells from the mice treated with induced-Treg cells suppress collagen-induced arthritis.

Authors:  Jie Yang; Yiming Yang; Huahua Fan; Hejian Zou
Journal:  J Immunol Res       Date:  2014-10-27       Impact factor: 4.818

8.  Undenatured type II collagen (UC-II®) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers.

Authors:  James P Lugo; Zainulabedin M Saiyed; Francis C Lau; Jhanna Pamela L Molina; Michael N Pakdaman; Arya Nick Shamie; Jay K Udani
Journal:  J Int Soc Sports Nutr       Date:  2013-10-24       Impact factor: 5.150

9.  Gene Therapy Induces Antigen-Specific Tolerance in Experimental Collagen-Induced Arthritis.

Authors:  Sara Tengvall; Tove Eneljung; Pernilla Jirholt; Olof Turesson; Kajsa Wing; Rikard Holmdahl; Jan Kihlberg; Anna Stern; Inga-Lill Mårtensson; Louise Henningsson; Kenth Gustafsson; Inger Gjertsson
Journal:  PLoS One       Date:  2016-05-09       Impact factor: 3.240

Review 10.  Self-antigen presentation by dendritic cells in autoimmunity.

Authors:  Ann-Katrin Hopp; Anne Rupp; Veronika Lukacs-Kornek
Journal:  Front Immunol       Date:  2014-02-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.